Neumora Therapeutics, Inc.股价拉升12.57% 市值涨4503.55万美元

市场透视01-03

北京时间2025年01月03日22时31分，Neumora Therapeutics, Inc.（NMRA.us）股票出现波动，股价大幅上涨12.57%。截至发稿，该股报2.22美元/股，成交量368.059万股，换手率2.28%，振幅9.14%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-72.55百万美元，每股收益-0.45美元，毛利-156000.00美元，市盈率-1.85倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2500111002?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-03 22:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2500111002","market":"us","top_or_hot":-1,"title":"Neumora Therapeutics, Inc.股价拉升12.57% 市值涨4503.55万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年01月03日22时31分，Neumora Therapeutics, Inc.（NMRA.us）股票出现波动，股价大幅上涨12.57%。截至发稿，该股报2.22美元/股，成交量368.059万股，换手率2.28%，振幅9.14%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-72.55百万美元，每股收益-0.45美元，毛利-156000.00美元，市盈率-1.85倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223159a21468e5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neumora Therapeutics, Inc.股价拉升12.57% 市值涨4503.55万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeumora Therapeutics, Inc.股价拉升12.57% 市值涨4503.55万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-03 22:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223159a21468e5&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年01月03日22时31分，Neumora Therapeutics, Inc.（NMRA.us）股票出现波动，股价大幅上涨12.57%。截至发稿，该股报2.22美元/股，成交量368.059万股，换手率2.28%，振幅9.14%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-72.55百万美元，每股收益-0.45美元，毛利-156000.00美元，市盈率-1.85倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223159a21468e5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223159a21468e5&s=b","article_id":"2500111002","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223159a21468e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2500111002","pubTimestamp":1735914719,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年01月03日22时31分，Neumora Therapeutics, Inc.股票出现波动，股价大幅上涨12.57%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","NMRA":"Neumora Therapeutics, Inc.","LENZ":"Therapeutics","BK4007":"制药"},"translate_title":"Neumora Therapeutics, Inc. 's stock price rose 12.57%, its market value rose by $45.0355 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"NMRA":1},"content_text":"北京时间2025年01月03日22时31分，Neumora Therapeutics, Inc.（NMRA.us）股票出现波动，股价大幅上涨12.57%。截至发稿，该股报2.22美元/股，成交量368.059万股，换手率2.28%，振幅9.14%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-72.55百万美元，每股收益-0.45美元，毛利-156000.00美元，市盈率-1.85倍。机构评级方面，在所有8家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Apollomics Inc C/Wts 01/04/2028 (To Pur Ord)、Scorpius Holdings, Inc.涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为868.93%、548.80%、255.77%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.、Oruka Therapeutics, Inc.，振幅分别为55.92%、26.06%、10.22%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。 它已经迅速扩大了其治疗管道，目前由七个临床和临床前神经科学项目组成，这些项目针对广泛的服务不足的神经精神疾病和神经退行性疾病的新作用机制。 该公司预计将继续推进其管道的开发，计划在未来 12 至 18 个月内启动多个项目的临床试验，这支持大量预期的数据读出。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2500111002"}